Alvotech (ALVO)
USD 8.77
(6.95%)
USD 8.77
(6.95%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.06 Billion USD | 44.08% |
| 2022 | 738.67 Million USD | 46.13% |
| 2021 | 505.49 Million USD | -21.65% |
| 2020 | 645.15 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.17 Billion USD | 13.76% |
| 2024 Q1 | 1.03 Billion USD | -2.75% |
| 2023 Q2 | 843.57 Million USD | 17.17% |
| 2023 FY | 1.06 Billion USD | 44.08% |
| 2023 Q4 | 1.06 Billion USD | 12.42% |
| 2023 Q3 | 946.71 Million USD | 12.23% |
| 2023 Q1 | 719.94 Million USD | -2.54% |
| 2022 Q1 | -386.76 Thousand USD | -100.08% |
| 2022 FY | 738.67 Million USD | 46.13% |
| 2022 Q4 | 738.67 Million USD | 18.39% |
| 2022 Q3 | 623.9 Million USD | 12.79% |
| 2022 Q2 | 553.17 Million USD | 143126.94% |
| 2021 Q3 | -799.55 Thousand USD | 4.18% |
| 2021 Q4 | 505.49 Million USD | 63322.36% |
| 2021 Q2 | -834.45 Thousand USD | 13.74% |
| 2021 Q1 | -967.4 Thousand USD | 16.5% |
| 2021 FY | 505.49 Million USD | -21.65% |
| 2020 Q2 | 134.05 Million USD | 0.0% |
| 2020 Q1 | 134.05 Million USD | 0.0% |
| 2020 Q4 | -1.15 Million USD | -100.86% |
| 2020 Q3 | 134.05 Million USD | 0.0% |
| 2020 FY | 645.15 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Bright Green Corporation | 1.84 Million USD | -57689.169% |
| Alpha Teknova, Inc. | 1.97 Million USD | -53816.768% |
| ANI Pharmaceuticals, Inc. | 94.2 Million USD | -1029.764% |
| Aquestive Therapeutics, Inc. | 74.95 Million USD | -1320.036% |
| Collegium Pharmaceutical, Inc. | 435.33 Million USD | -144.482% |
| Cosmos Health Inc. | 8.59 Million USD | -12289.094% |
| Journey Medical Corporation | -9.7 Million USD | 11062.169% |
| Embecta Corp. | 1.31 Billion USD | 18.878% |
| Esperion Therapeutics, Inc. | 458.69 Million USD | -132.03% |
| Dynavax Technologies Corporation | 106.63 Million USD | -898.093% |
| Intra-Cellular Therapies, Inc. | -130.82 Million USD | 913.518% |
| Pacira BioSciences, Inc. | 432.74 Million USD | -145.945% |
| PainReform Ltd. | -7.95 Million USD | 13487.635% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 6907.428% |
| Sunshine Biopharma, Inc. | -15.63 Million USD | 6907.428% |
| SCYNEXIS, Inc. | -19.35 Million USD | 5600.346% |
| Safety Shot Inc | -2.28 Million USD | 46691.168% |
| China SXT Pharmaceuticals, Inc. | -9.42 Million USD | 11386.821% |
| Procaps Group, S.A. | 242.93 Million USD | -338.113% |
| Theratechnologies Inc. | 24.87 Million USD | -4179.349% |
| Harrow Health, Inc. | 116.41 Million USD | -814.228% |
| Sonoma Pharmaceuticals, Inc. | -2.52 Million USD | 42334.802% |
| Biofrontera Inc. | 4.05 Million USD | -26140.557% |
| DURECT Corporation | -7.65 Million USD | 14005.37% |
| Supernus Pharmaceuticals, Inc. | -33.52 Million USD | 3274.507% |
| Cronos Group Inc. | -663.32 Million USD | 260.451% |
| OptiNose, Inc. | 58.06 Million USD | -1732.975% |
| Ironwood Pharmaceuticals, Inc. | 623.38 Million USD | -70.732% |
| Kala Pharmaceuticals, Inc. | -14.57 Million USD | 7403.85% |
| RedHill Biopharma Ltd. | -5.18 Million USD | 20622.766% |
| Organogenesis Holdings Inc. | 15.01 Million USD | -6989.303% |
| Guardion Health Sciences, Inc. | -6.35 Million USD | 16835.476% |
| Cumberland Pharmaceuticals Inc. | 106.85 Thousand USD | -995901.273% |
| Radius Health, Inc. | 359.28 Million USD | -196.235% |
| Universe Pharmaceuticals INC | 197.2 Thousand USD | -539589.872% |
| ProPhase Labs, Inc. | 19.23 Million USD | -5434.382% |
| Phibro Animal Health Corporation | 454.84 Million USD | -133.995% |
| Procaps Group S.A. | 242.93 Million USD | -338.113% |
| TherapeuticsMD, Inc. | 3.67 Million USD | -28837.384% |
| Viatris Inc. | 17.13 Billion USD | 93.787% |
| Rockwell Medical, Inc. | 4.45 Million USD | -23785.031% |
| Aytu BioPharma, Inc. | -4.87 Million USD | 21923.19% |
| SIGA Technologies, Inc. | -148.68 Million USD | 815.835% |
| Tilray Brands, Inc. | 158.97 Million USD | -569.479% |
| Lifecore Biomedical, Inc. | 121.89 Million USD | -773.121% |
| Shineco, Inc. | 29.29 Million USD | -3533.684% |
| PetIQ, Inc. | 351.93 Million USD | -202.42% |
| Regencell Bioscience Holdings Limited | -2.9 Million USD | 36782.523% |
| Incannex Healthcare Limited | -5.48 Million USD | 19504.139% |
| Neurocrine Biosciences, Inc. | 177.3 Million USD | -500.292% |
| Alimera Sciences, Inc. | 55.3 Million USD | -1824.311% |
| Silver Spike Investment Corp. | -32.61 Million USD | 3363.611% |
| Assertio Holdings, Inc. | -32.52 Million USD | 3371.902% |
| Shuttle Pharmaceuticals Holdings, Inc. | -1.48 Million USD | 71591.991% |
| Petros Pharmaceuticals, Inc. | -5.06 Million USD | 21132.337% |
| Clever Leaves Holdings Inc. | -4.81 Million USD | 22208.787% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 13058.178% |
| Avadel Pharmaceuticals plc | 4.21 Million USD | -25138.724% |
| Hempacco Co., Inc. | 13.61 Million USD | -7717.422% |
| Talphera, Inc. | -5.72 Million USD | 18703.688% |
| Alvotech | 1.06 Billion USD | 0.0% |
| Eagle Pharmaceuticals, Inc. | 7.14 Million USD | -14795.969% |
| Lantheus Holdings, Inc. | -96.71 Million USD | 1200.524% |
| Currenc Group, Inc. | -16.57 Million USD | 6521.945% |
| Kamada Ltd. | -46.43 Million USD | 2392.23% |
| Indivior PLC | -33.95 Million USD | 3234.77% |
| Evoke Pharma, Inc. | 260.57 Thousand USD | -408350.958% |
| Flora Growth Corp. | -713 Thousand USD | 149373.072% |
| Cyclo Therapeutics, Inc. | -8.21 Million USD | 13058.178% |
| Evolus, Inc. | 63.7 Million USD | -1570.618% |
| HUTCHMED (China) Limited | -197.45 Million USD | 639.009% |
| Amphastar Pharmaceuticals, Inc. | 479.11 Million USD | -122.144% |
| Akanda Corp. | 3.9 Million USD | -27155.823% |